Other functions - preclinical in vitro and in vivo agent development assays.
Ended Awarded Last action
- Contract number
- HHSN261201200019I
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $2,759 obligated
Award facts
- Combined order value
- $2,759 Current and potential, with all options
- Last date to order 100% complete
- Maximum order
- $9,900,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The contract, with a ceiling value of $0, is part of the Preclinical Agent Development Assays 2012-2016 program and supports preclinical in vitro and in vivo agent development assays.
Under this IDC, IITRI provides a range of preclinical research services to support Investigational New Drug (IND) applications, including pharmacology, toxicology, safety, and efficacy evaluations of small molecule, biologic, and RNA therapeutic candidates across various disease areas. The contract has facilitated IITRI's work on projects such as the preclinical development of an RNA vaccine for prostate cancer prevention, safety assessments of compounds for neuropathic pain and acute cannabinoid overdose, and toxicology testing of COVID-19 related therapies. IITRI has also conducted subcontract work for other research institutions, performing specialized studies such as repeat dose toxicity evaluations of multivalent vaccines.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Other functions - preclinical in vitro and in vivo agent development assays - OA orientation meeting iitri… | National Cancer Institute (NIH) | $2,759 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201200019I?
HHSN261201200019I was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 20, 2012.
How much is contract HHSN261201200019I worth?
Orders under HHSN261201200019I have obligated $2,759. A single order can be worth up to $9,900,000.
How many orders have been placed under contract HHSN261201200019I?
1 order has been placed under HHSN261201200019I, the latest on September 20, 2012.
Who can order from contract HHSN261201200019I?
HHSN261201200019I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201200019I part of a contract vehicle?
Yes. HHSN261201200019I is part of Preclinical Agent Development Assays 2012-2016.
Was contract HHSN261201200019I competed?
The extent of competition for HHSN261201200019I was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV